| aPTT | Activated partial thromboplastin time |
| BID | Twice daily |
| BMI | Body mass index |
| °C | Degree Celsius |
| CI | Confidence interval |
| CIS | COVID-19 inflammation score |
| CoV-2 | Coronavirus type 2 |
| COVID-19 | Coronavirus disease 2019 |
| CRP | C-reactive protein |
| Ct | Cycle threshold |
| CT | Computed tomography |
| ECMO | Extracorporeal membrane oxygenation |
| FDA | Food and Drug Administration |
| G/L | Giga/liter |
| HR | Hazard ratio |
| ICU | Intensive care unit |
| IFN-γ | Interferon-γ, |
| IL-6 | Interleukin-6 |
| JAK | Janus kinase |
| mg/L | Milligram/liter |
| MPN | Myeloproliferative neoplasm |
| OR | Odds ratio |
| Pts | Patients |
| RRT | Renal replacement therapy |
| Rux | Ruxolitinib |
| SAPS II | Simplified Acute Physiology Score II |
| SOFA | Sequential Organ Failure Assessment |
| SpO2 | Peripheral arterial oxygen saturation |
| ULN | Upper limit of normal |
| US | United states |
| WBC | White blood cell |
| WHO | World Health Organization |